Skip to main content
. 2016 Dec 15;2016(12):CD006918. doi: 10.1002/14651858.CD006918.pub3

1.14. Analysis.

1.14

Comparison 1 RISPERIDONE vs PLACEBO, Outcome 14 Adverse effects: 5. endocrine ‐ serum prolactin increase above reference range (23 ng/ml) ‐ short term (up to 12 weeks).